What is the recommended treatment for an infant experiencing allergic symptoms, specifically the use of oral antihistamines (e.g. diphenhydramine, loratadine) and ophthalmic antihistamines (e.g. ketotifen, azelastine)?

Antihistamine Use in Infants: Treatment Recommendations

Direct Answer

For infants with allergic symptoms, second-generation oral antihistamines (cetirizine or loratadine) are the recommended first-line treatment, while first-generation antihistamines like diphenhydramine should be avoided due to significant safety concerns, and ophthalmic antihistamines are not approved for use in this age group. 1

---

Oral Antihistamines: What to Use

Second-Generation Antihistamines (Preferred)

Cetirizine and loratadine are the only appropriate oral antihistamines for infants, with established safety profiles and FDA approval for young children. 1, 2

• For infants 6-11 months: Cetirizine can be dosed at 0.25 mg/kg twice daily (approximately 2.5 mg twice daily for a 10 kg infant) 2, 3, 4
• For children 2-5 years: Cetirizine 2.5 mg once or twice daily, or loratadine 5 mg once daily 1, 3
• Liquid formulations are strongly preferred in infants for easier administration and better absorption 1
• These medications have been shown to be well-tolerated with very good safety profiles in young children 1, 2

Critical Safety Warning: Avoid First-Generation Antihistamines

Diphenhydramine and other first-generation antihistamines should never be used in children under 6 years of age for routine allergic symptoms. 1

• Between 1969-2006, there were 69 deaths associated with antihistamines in children under 6 years, with diphenhydramine responsible for 33 of these deaths 1, 3
• The FDA's Nonprescription Drugs and Pediatric Advisory Committees explicitly recommend that OTC cough and cold medications (including first-generation antihistamines) no longer be used in children below 6 years of age 1, 3
• First-generation antihistamines cause significant sedation, central nervous system toxicity, and have been associated with fatal overdoses in young children 1

---

Ophthalmic Antihistamines: Not Recommended

Ophthalmic antihistamines (ketotifen, azelastine eye drops) are not approved for use in infants and should be avoided. 3

• Intranasal antihistamines are not approved in children under 6 years due to lack of safety data 3
• While azelastine nasal spray has been studied in older children (6+ years), there is no evidence supporting ophthalmic formulations in infants 5, 6
• For ocular symptoms in infants, second-generation oral antihistamines provide systemic relief including eye symptoms 3

---

Clinical Algorithm for Infant Allergic Symptoms

Step 1: Identify the Clinical Scenario

• Mild symptoms (few hives, mild itching, watery eyes): Start with second-generation oral antihistamine 7
• Moderate-to-severe symptoms (diffuse hives, respiratory symptoms, tongue/lip swelling): This is anaphylaxis—administer epinephrine immediately, antihistamines are only adjunctive 7
• Chronic symptoms (persistent rhinitis, urticaria): Consider referral to pediatric allergist while initiating second-generation antihistamine 1

Step 2: Select Appropriate Medication

• First choice: Cetirizine 0.25 mg/kg twice daily (liquid formulation) 2, 4
• Alternative: Loratadine 5 mg once daily for children ≥2 years 1
• Never use: Diphenhydramine, other first-generation antihistamines, or ophthalmic antihistamines 1, 3

Step 3: Monitor and Adjust

• Cetirizine may cause mild drowsiness, particularly in low body weight infants—consider evening dosing if this occurs 3
• If renal impairment is present, halve the cetirizine dose 2, 3
• Discontinue antihistamines 5-7 days before any allergy testing 2

---

Important Caveats and Pitfalls

What Antihistamines Cannot Do

• Antihistamines should never replace epinephrine in anaphylaxis—they are adjunctive therapy only and cannot reverse severe allergic reactions 7, 2
• Do not use antihistamines prophylactically to prevent wheezing or asthma in infants with atopic dermatitis or family history of allergy, as risks outweigh uncertain benefits 1
• Never use antihistamines "to make a child sleepy"—this is explicitly contraindicated per FDA labeling 1

Avoid OTC Combination Products

• OTC cough and cold combination products should never be used in children under 6 years due to overdose risk and lack of efficacy 1, 2, 3
• Between 1969-2006, there were 54 fatalities associated with decongestants in children under 6 years 3
• Oral decongestants have been associated with agitated psychosis, ataxia, hallucinations, and death in young children 3

When to Consider Alternative Therapy

• If symptoms persist despite antihistamines: Intranasal corticosteroids are more effective than antihistamines for allergic rhinitis, with fluticasone propionate approved for children ≥4 years and mometasone furoate for ≥3 years 3, 8
• For infants 6 months to 2 years with perennial allergic rhinitis: Montelukast is the only FDA-approved medication, though less effective than intranasal corticosteroids 3
• For food allergies: Avoidance is first-line treatment; prescribe both antihistamines and epinephrine autoinjector for all children with likely food allergy 7

---

Special Considerations for Emergency Situations

In anaphylaxis, the treatment hierarchy is critical: 7

• Epinephrine is the only first-line treatment and can be dosed every 5-15 minutes if symptoms persist 7
• Antihistamines (both H1 and H2) are adjunctive therapy to prevent biphasic reactions and cardiac deficit 7
• Corticosteroids have limited immediate benefit but prevent late-onset immune mediator activation 7
• Patients should carry 2 epinephrine autoinjectors in case a second dose is needed 7